3/5/2025 | | A Docket Text Order with Schedules |
2/25/2025 | | A Docket Text Order |
2/25/2025 | 81 | Pro Hac Vice |
1/29/2025 | 80 | Order (will rule a motion and set/satisfy a schedule) |
1/6/2025 | 79 | Docket Text ORDER: Re: 78 MOTION to Withdraw as Attorney re attorney/firm Lowell Pearson by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Pearson, Lowell); ORDERED GRANTED. Signed by Chief District Judge Stephen R. Clark on 1/6/25. (JAB) (Entered: 01/06/2025) |
1/3/2025 | 78 | MOTION to Withdraw as Attorney re attorney/firm Lowell Pearson by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Pearson, Lowell) (Entered: 01/03/2025) |
12/19/2024 | 77 | NOTICE of Supplemental Authority re 32 MOTION to Dismiss Case by Plaintiffs AbbVie Inc., Allergan, Inc., Durata Therapeutics, Inc., Abbvie Products LLC, Aptalis Pharma US, Inc., Pharmacyclics LLC, Allergan Sales, LLC in Support of Plaintiffs' Opposition to Motion to Dismiss. (Attachments: # 1 Exhibit 12.17.2024 Opinion of D. W. Va. Court)(Pake, Lisa) (Entered: 12/19/2024) |
11/21/2024 | 76 | Docket Text ORDER: The Court grants Ronald S. Connelly's 75 Motion for Leave to Appear Pro Hac Vice. Signed by Chief District Judge Stephen R. Clark on 11/21/24. (JAB) (Entered: 11/21/2024) |
11/20/2024 | 75 | MOTION for Leave to Appear Pro Hac Vice Ronald S. Connelly. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10948704) by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Attachments: # 1 Certificate of Good Standing)(Connelly, Ronald) (Entered: 11/20/2024) |
11/19/2024 | 74 | NOTICE of Supplemental Authority re 46 MOTION to Intervene and Suggestions in Support by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association . (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Monafo, James) (Entered: 11/19/2024) |
11/4/2024 | 73 | REPLY to Response to Motion re 46 MOTION to Intervene and Suggestions in Support filed by intervenors Missouri Hospital Association and Missouri Primary Care Association (Monafo, James) Modified on 11/5/2024; corrected filer. (JAB). (Entered: 11/04/2024) |
10/25/2024 | 72 | MEMORANDUM in Opposition re 46 MOTION to Intervene and Suggestions in Support filed by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 10/25/2024) |
10/24/2024 | 71 | DISCLOSURE STATEMENT by American Hospital Association. No corporate parents or affiliates identified. (Phillips, Jerina) (Entered: 10/24/2024) |
10/24/2024 | 70 | DISCLOSURE STATEMENT by 340B Health. No corporate parents or affiliates identified. (Phillips, Jerina) (Entered: 10/24/2024) |
10/24/2024 | 69 | DISCLOSURE STATEMENT by American Society of Health-System Pharmacists. No corporate parents or affiliates identified. (Phillips, Jerina) (Entered: 10/24/2024) |
10/23/2024 | 68 | Electronic Notice re: Disclosure Statement to Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. Pursuant to Local Rule 2.09, every nongovernmental corporate party or nongovernmental corporation that seeks to intervene in any case, and every party or intervenor in an action in which jurisdiction is based upon diversity, must file a Disclosure Statement immediately upon entering its appearance in the case. Please complete and file the certificate as soon as possible and add all individuals and entities into CM/ECF as required (moed-0001.pdf). (LNJ) (Entered: 10/23/2024) |
10/21/2024 | 67 | REPLY to Response to Motion re 32 MOTION to Dismiss Case filed by Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Barceleau, Dominic) (Entered: 10/21/2024) |
10/10/2024 | 66 | MOTION for Hearing re 32 MOTION to Dismiss Case by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 10/10/2024) |
10/10/2024 | 65 | MEMORANDUM in Opposition re 32 MOTION to Dismiss Case filed by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 10/10/2024) |
10/9/2024 | 63 | Docket Text ORDER: The Court grants AbbVie's 60 Consent Motion for Extension of Time to Respond to Motion to Intervene. (Response to Court due by 10/25/2024.) Signed by Chief District Judge Stephen R. Clark on 10/9/2024. (LNJ) (Entered: 10/09/2024) |
10/8/2024 | 62 | Docket Text ORDER: The Court grants 58 Consent MOTION for Leave to File in Excess of Page Limitation - for Response in Opposition to Defendants' Motion to Dismiss by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. Signed by Chief District Judge Stephen R. Clark on 10/8/2024. (LNJ) (Entered: 10/08/2024) |
10/7/2024 | 64 | BRIEF in Support of Motion re 32 MOTION to Dismiss Case filed by Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. (JAB) (Entered: 10/10/2024) |
10/7/2024 | 61 | Docket Text ORDER: The Court grants Proposed Amici's 34 Motion for Leave to File Amicus Brief in Support of Defendants' Motion to Dismiss. Signed by Chief District Judge Stephen R. Clark on 10/7/2024. (TLR) (Entered: 10/08/2024) |
10/7/2024 | 60 | Consent MOTION for Extension of Time to File Response/Reply - to Respond to Motion to Intervene by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 10/07/2024) |
10/7/2024 | 59 | MEMORANDUM in Support of Motion re 58 Consent MOTION for Leave to File in Excess of Page Limitation - for Response in Opposition to Defendants' Motion to Dismiss filed by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 10/07/2024) |
10/7/2024 | 58 | Consent MOTION for Leave to File in Excess of Page Limitation - for Response in Opposition to Defendants' Motion to Dismiss by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 10/07/2024) |
10/3/2024 | 57 | Docket Text ORDER: The Court grants Lowell D. Pearson's 56 Motion for Leave to Appear Pro Hac Vice. Signed by Chief District Judge Stephen R. Clark on 10/3/2024. (LNJ) (Entered: 10/03/2024) |
10/3/2024 | 56 | MOTION for Leave to Appear Pro Hac Vice Lowell D. Pearson. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10862097) by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Attachments: # 1 Certificate of Good Standing Certificate of Good Standing)(Pearson, Lowell) (Entered: 10/03/2024) |
9/30/2024 | 55 | AMENDED DISCLOSURE STATEMENT by Missouri Hospital Association. No corporate parents or affiliates identified. (Monafo, James) Modified on 10/25/2024 (CBL). (Entered: 09/30/2024) |
9/30/2024 | 54 | AMENDED DISCLOSURE STATEMENT by Missouri Primary Care Association. No corporate parents or affiliates identified. (Monafo, James) Modified on 10/25/2024 (CBL). (Entered: 09/30/2024) |
9/30/2024 | 53 | NOTICE of Filing Deficiency re 50 Disclosure Statement, 49 Disclosure Statement filed by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. In accordance with Eastern District of Missouri Local Rules and the Case Management/Electronic Case Filing (CM/ECF) Procedures Manual, a filing deficiency has been identified as follows: Party filed the Disclosure Statement in which jurisdiction is based on a Federal Question, but did use the Court adopted form, which was adopted in March 2023, when Local Rule 2.09 was revised. Please complete Section 1 of the correct form for each proposed individual intervenor entity, identifying whether it is publicly traded and, if so, on which exchange(s); parent companies or corporations; subsidiaries not wholly owned, and any publicly held corporation or company that owns five percent (5%) or more of the subject's stock. These entities must be entered into CM/ECF where prompted. An amended Disclosure Statement must be filed immediately, using the Court adopted form. (moed-0001.pdf). (CBL) (Entered: 09/30/2024) |
9/27/2024 | 52 | ENTRY of Appearance by Alexa Brianne Barton for Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Barton, Alexa) (Entered: 09/27/2024) |
9/27/2024 | 51 | ENTRY of Appearance by Tanner Cook for Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Cook, Tanner) (Entered: 09/27/2024) |
9/27/2024 | 50 | DISCLOSURE STATEMENT by Missouri Primary Care Association. No corporate parents or affiliates identified. (Monafo, James) (Entered: 09/27/2024) |
9/27/2024 | 49 | DISCLOSURE STATEMENT by Missouri Hospital Association. No corporate parents or affiliates identified. (Monafo, James) (Entered: 09/27/2024) |
9/27/2024 | 48 | MEMORANDUM in Support of Motion re 47 MOTION to Dismiss Case filed by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Monafo, James) (Entered: 09/27/2024) |
9/27/2024 | 47 | MOTION to Dismiss Case by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Monafo, James) (Entered: 09/27/2024) |
9/27/2024 | 46 | MOTION to Intervene and Suggestions in Support by Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Attachments: # 1 Exhibit A - Declaration of Andrew Wheeler, # 2 Exhibit B - Declaration of Joseph Pierle)(Monafo, James) (Entered: 09/27/2024) |
9/27/2024 | 45 | ENTRY of Appearance by James F. Monafo for Intervenor Parties Missouri Hospital Association, Missouri Primary Care Association. (Monafo, James) (Entered: 09/27/2024) |
9/26/2024 | 44 | Docket Text ORDER: The Court grants Margaret M. Dotzel's 43 Motion for Leave to Appear Pro Hac Vice. Signed by Chief District Judge Stephen R. Clark on 9/26/24. (JAB) (Entered: 09/26/2024) |
9/26/2024 | 43 | MOTION for Leave to Appear Pro Hac Vice Margaret M. Dotzel. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10850334) by Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. (Attachments: # 1 Certificate of Good Standing)(Dotzel, Margaret) (Entered: 09/26/2024) |
9/24/2024 | 42 | Docket Text ORDER: Re: 38 Consent MOTION for Extension of Time to File Response as to 32 MOTION to Dismiss Case by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) ; ORDERED GRANTED. ( Response to Court due by 10/10/2024) Signed by Chief District Judge Stephen R. Clark on 9/24/24. (JAB) (Entered: 09/24/2024) |
9/23/2024 | 41 | Docket Text ORDER: The Court grants William B. Schultz's 39 Motion for Leave to Appear Pro Hac Vice and Alyssa Howard Card's 40 Motion for Leave to Appear Pro Hac Vice. Signed by Chief District Judge Stephen R. Clark on 9/23/24. (JAB) (Entered: 09/24/2024) |
9/23/2024 | 40 | MOTION for Leave to Appear Pro Hac Vice Alyssa Howard Card. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10842533) by Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. (Attachments: # 1 Certificate of Good Standing)(Card, Alyssa) (Entered: 09/23/2024) |
9/23/2024 | 39 | MOTION for Leave to Appear Pro Hac Vice William B. Schultz. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10842460) by Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. (Attachments: # 1 Certificate of Good Standing)(Schultz, William) (Entered: 09/23/2024) |
9/23/2024 | 38 | Consent MOTION for Extension of Time to File Response/Reply as to 32 MOTION to Dismiss Case by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 09/23/2024) |
9/20/2024 | 37 | ENTRY of Appearance by Neal F. Perryman for Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. (Perryman, Neal) Modified text on 9/25/2024 (JAB). (Entered: 09/20/2024) |
9/20/2024 | 36 | ENTRY of Appearance by Jerina Dominique Phillips for Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. (Phillips, Jerina) (Entered: 09/20/2024) |
9/19/2024 | 35 | MEMORANDUM in Support of Motion re 34 MOTION for Leave to File Amicus Brief in Support of Defendants' Motion to Dismiss filed by Amicus Parties 340B Health, American Hospital Association, American Society of Health-System Pharmacists. (Phillips, Jerina) (Entered: 09/19/2024) |
9/19/2024 | 34 | MOTION for Leave to File Amicus Brief in Support of Defendants' Motion to Dismiss by Amicus Parties 340B Health, American Society of Health-System Pharmacists, American Hospital Association. (Attachments: # 1 Exhibit A - Brief of Amici Curiae in Support of Defendants' Motion to Dismiss)(Phillips, Jerina) (Entered: 09/19/2024) |
9/12/2024 | 33 | MEMORANDUM in Support of Motion re 32 MOTION to Dismiss Case filed by Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Barceleau, Dominic) (Entered: 09/12/2024) |
9/12/2024 | 32 | MOTION to Dismiss Case by Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Barceleau, Dominic) (Entered: 09/12/2024) |
9/11/2024 | 31 | ENTRY of Appearance by Dominic Barceleau for Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Barceleau, Dominic) (Entered: 09/11/2024) |
9/9/2024 | 30 | ORDER: The Court grants Defendants' 28 Motion for Leave to File an Overlength Motion to Dismiss. The Court encourages counsel to be as concise as possible. Signed by Chief District Judge Stephen R. Clark on 9/9/2024. (TLR) (Entered: 09/09/2024) |
9/4/2024 | 29 | MEMORANDUM in Support of Motion re 28 MOTION for Leave to File an Overlength Motion to Dismiss filed by Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Lanahan, Maria) (Entered: 09/04/2024) |
9/4/2024 | 28 | MOTION for Leave to File an Overlength Motion to Dismiss by Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Lanahan, Maria) (Entered: 09/04/2024) |
8/1/2024 | 27 | Docket Text ORDER: Re: 26 Consent MOTION for Extension of Time to File Answer or Otherwise Respond to Complaint by Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson; ORDERED GRANTED. (All Defendants Answer due September 12, 2024). Signed by Chief District Judge Stephen R. Clark on 8/1/2024. (LNJ) (Entered: 08/01/2024) |
7/31/2024 | 26 | Consent MOTION for Extension of Time to File Answer or Otherwise Respond to Complaint by Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Lanahan, Maria) (Entered: 07/31/2024) |
7/31/2024 | 25 | ENTRY of Appearance by Maria Ann Lanahan for Defendants Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson. (Lanahan, Maria) (Entered: 07/31/2024) |
7/31/2024 | 24 | Docket Text ORDER: The Court grants Matthew Owen's 21 Motion for Leave to Appear Pro Hac Vice, Meredith Pohl's 22 Motion for Leave to Appear Pro Hac Vice, and Michael Pronin's 23 Motion for Leave to Appear Pro Hac Vice. Signed by Chief District Judge Stephen R. Clark on 7/31/24. (JAB) (Entered: 07/31/2024) |
7/30/2024 | 23 | MOTION for Leave to Appear Pro Hac Vice Michael A. Pronin. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10739847) by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Attachments: # 1 Certificate of Good Standing -DC for M. Pronin)(Pronin, Michael) (Entered: 07/30/2024) |
7/30/2024 | 22 | MOTION for Leave to Appear Pro Hac Vice Meredith Pohl. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10739804) by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Attachments: # 1 Certificate of Good Standing -DC for M. Pohl)(Pohl, Meredith) (Entered: 07/30/2024) |
7/30/2024 | 21 | MOTION for Leave to Appear Pro Hac Vice Matthew S. Owen. The Certificate of Good Standing was attached.(Filing fee $150 receipt number AMOEDC-10739779) by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Attachments: # 1 Certificate of Good Standing -DC for Matt Owen)(Owen, Matthew) (Entered: 07/30/2024) |
7/29/2024 | 20 | ENTRY of Appearance by Lisa A. Pake for Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC. (Pake, Lisa) (Entered: 07/29/2024) |
7/29/2024 | 19 | DISCLOSURE STATEMENT by Allergan Sales, LLC, Allergan Holdings, Inc., Allergan Holdco US, Inc., AbbVie Inc. (Ultimate Parent), AbbVie Corporation, AbbVie S.A.S., AbbVie Services, Inc., Allergan Development Ventures I, L.P., Allergan Holdings B1, Inc., Allergan Holdings, Inc., MAP Pharmaceuticals, LLC.. (Haar, Robert) (Entered: 07/29/2024) |
7/29/2024 | 18 | DISCLOSURE STATEMENT by Pharmacyclics LLC, AbbVie Inc... (Haar, Robert) (Entered: 07/29/2024) |
7/29/2024 | 17 | DISCLOSURE STATEMENT by Aptalis Pharma US, Inc., Allergan Sales, LLC, AbbVie Inc. (Ultimate Parent).. (Haar, Robert) (Entered: 07/29/2024) |
7/29/2024 | 16 | DISCLOSURE STATEMENT by Abbvie Products LLC, AbbVie Inc... (Haar, Robert) (Entered: 07/29/2024) |
7/29/2024 | 15 | DISCLOSURE STATEMENT by Durata Therapeutics, Inc., Allergan W.C. Holding Inc., AbbVie Inc. (Ultimate Parent).. (Haar, Robert) (Entered: 07/29/2024) |
7/29/2024 | 14 | DISCLOSURE STATEMENT by Allergan, Inc., Allergan Finance, LLC, AbbVie Inc. (Ultimate Parent), AbbVie Healthcare India Private Limited, Abbvie Productos Farmaceuticos Limitada, AbbVie S.A., AbbVie S.A.S., Allergan Holdings, Inc., MAP Pharmaceuticals, LLC.. (Haar, Robert) (Entered: 07/29/2024) |
7/29/2024 | 13 | DISCLOSURE STATEMENT by AbbVie Inc., AbbVie Corporation, AbbVie Farmaceuticos Sociedad Anonima de Capital Variable, AbbVie Group Holdings Limited, The Vanguard Group, Blackrock, Inc... (Haar, Robert) (Entered: 07/29/2024) |
7/25/2024 | 12 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. Darren Harris served on 7/23/2024, answer due 8/13/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/25/2024 | 11 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. Tammy Thompson served on 7/23/2024, answer due 8/13/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/25/2024 | 10 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. Colby Grove served on 7/23/2024, answer due 8/13/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/25/2024 | 9 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. Anita K. Parran served on 7/23/2024, answer due 8/13/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/25/2024 | 8 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. Douglas R. Lang served on 7/23/2024, answer due 8/13/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/25/2024 | 7 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. Christian S. Tadrus served on 7/23/2024, answer due 8/13/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/25/2024 | 6 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. James L. Gray served on 7/23/2024, answer due 8/13/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/25/2024 | 5 | SUMMONS Returned Executed filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. Andrew Bailey served on 7/24/2024, answer due 8/14/2024. (Haar, Robert) (Entered: 07/25/2024) |
7/23/2024 | 4 | Docket Text ORDER: The Court orders the parties to review and comply with the undersigned's Judge's Requirements, located on the Eastern District of Missouri's court website: Chief Judge Stephen R. Clark's Requirements. The undersigned periodically updates his Judge's Requirements, and the parties must ensure that they are complying with the most recent version before filing any document. Failure to comply with the requirements may result in the imposition of "sanction[s] or other disadvantage." Fed. R. Civ. P. 83(b). Signed by Chief District Judge Stephen R. Clark on 7/23/2024. (LNJ) (Entered: 07/23/2024) |
7/22/2024 | | Case Opening Notification. Judge Assigned: Honorable Stephen R. Clark. 8 Summons(es) issued and emailed to attorney Robert Haar. Pursuant to Local Rule 2.09, every nongovernmental corporate party or nongovernmental corporation that seeks to intervene in any case, and every party or intervenor in an action in which jurisdiction is based upon diversity, must file a Disclosure Statement immediately upon entering its appearance in the case. Please complete and file the certificate as soon as possible. (moed-0001.pdf). (JWD) (Entered: 07/22/2024) |
7/22/2024 | 3 | NOTICE OF PROCESS SERVER by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC Process Server: Rufus Harmon (Haar, Robert) (Entered: 07/22/2024) |
7/22/2024 | 2 | NOTICE OF PROCESS SERVER by Plaintiffs AbbVie Inc., Abbvie Products LLC, Allergan Sales, LLC, Allergan, Inc., Aptalis Pharma US, Inc., Durata Therapeutics, Inc., Pharmacyclics LLC Process Server: Marybeth Rice (Haar, Robert) (Entered: 07/22/2024) |
7/22/2024 | 1 | COMPLAINT for Declaratory and Injunctive Relief against defendant Andrew Bailey, James L. Gray, Colby Grove, Darren Harris, Douglas R. Lang, Anita K. Parran, Christian S. Tadrus, Tammy Thompson with receipt number AMOEDC-10722815, in the amount of $405 Non-Jury Demand,, filed by Pharmacyclics LLC, Durata Therapeutics, Inc., Allergan Sales, LLC, Allergan, Inc., AbbVie Inc., Abbvie Products LLC, Aptalis Pharma US, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Original Filing Form, # 3 Summons directed to Andrew Bailey, # 4 Summons directed to James L. Gray, # 5 Summons directed to Christian S. Tadrus, # 6 Summons directed to Douglas R. Lang, # 7 Summons directed to Anita K. Parran, # 8 Summons directed to Colby Grove, # 9 Summons directed to Tammy Thompson, # 10 Summons directed to Darren Harris)(Haar, Robert) (Entered: 07/22/2024) |